SCHEMBL6344682

SCHEMBL6344682

CC(C)c1nn(-c2ccccn2)c2nc3ccccc3c(Cl)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.39
PPARA Q07869 3/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
ALDH1A1 P00352 3/20 0.36
AURKA O14965 1/20 0.36
FLT3 P36888 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
HTT P42858 2/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PPARG P37231 1/20 0.35
KMT2A Q03164 1/20 0.34
HSP90AA1 P07900 1/20 0.34
METAP1 P53582 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6343061 0.84 ALDH1A1 (0.46) PIK3CDMAOAMAOBALDH1A1AURKA
SCHEMBL6341853 0.81 CCNE2 (0.40) MAOAMAOBALDH1A1AURKAFLT3
SCHEMBL6344238 0.80 ALDH1A1 (0.38) MAOAMAOBALDH1A1AURKAFLT3
SCHEMBL6342932 0.79 NR3C1 (0.37) MAOAMAOBALDH1A1AURKAFLT3
SCHEMBL5471065 0.78 MAOA (0.43) PPARAMAOAMAOBALDH1A1KDM4E
SCHEMBL6343804 0.76 KDM4E (0.50) MAOBALDH1A1KDM4EHPGDRAB9A
SCHEMBL6340244 0.75 SPR (0.47) PIK3CDALDH1A1KDM4EHPGDHTT
SCHEMBL6344817 0.75 MAOA (0.46) MAOAMAOBALDH1A1AURKAFLT3
SCHEMBL6342834 0.74 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDHTTMAPT
SCHEMBL6342505 0.74 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 PIK3CD 1404/4885PPARA 413/4885MAOA 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.